相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT
Hicham Skali et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Finerenone, a Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Protects From Rat Cardiorenal Injury
Peter Kolkhof et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2014)
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Clyde W. Yancy et al.
CIRCULATION (2013)
Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
Bertram Pitt et al.
EUROPEAN HEART JOURNAL (2013)
EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)
Aldo P. Maggioni et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure The ASTRONAUT Randomized Trial
Mihai Gheorghiade et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function Analyses of the EMPHASIS-HF Study Subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)
Romain Eschalier et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy
Stephen Orena et al.
FRONTIERS IN PHARMACOLOGY (2013)
Discovery of BAY 94-8862: A Nonsteroidal Antagonist of the Mineralocorticoid Receptor for the Treatment of Cardiorenal Diseases
Lars Baerfacker et al.
CHEMMEDCHEM (2012)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
John J. V. McMurray et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Update on Aldosterone Antagonists Use in Heart Failure With Reduced Left Ventricular Ejection Fraction Heart Failure Society of America Guidelines Committee
Javed Butler et al.
JOURNAL OF CARDIAC FAILURE (2012)
Molecular pharmacology of the mineralocorticoid receptor: Prospects for novel therapeutics
Peter Kolkhof et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline)
et al.
CIRCULATION (2011)
Identifying Patients Hospitalized With Heart Failure at Risk for Unfavorable Future Quality of Life
Larry A. Allen et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2011)
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Christian W. Hamm et al.
EUROPEAN HEART JOURNAL (2011)
Hospitalizations for Heart Failure in the United States-A Sign of Hope
Mihai Gheorghiade et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Improving Postdischarge Outcomes in Patients Hospitalized for Acute Heart Failure Syndromes
Mihai Gheorghiade et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Christian W. Hamm et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2011)
Effect of eplerenone versus spironolactone on cortisol and hemoglobin A1c levels in patients with chronic heart failure
Masayuki Yamaji et al.
AMERICAN HEART JOURNAL (2010)
Effect of Spironolactone on Left Ventricular Systolic and Diastolic Function in Patients With Early Stage Chronic Kidney Disease
Nicola C. Edwards et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Randomized, Double- Blind, Multicenter, Placebo-Controlled Study Evaluating the Effect of Aldosterone Antagonism With Eplerenone on Ventricular Remodeling in Patients With Mild-to-Moderate Heart Failure and Left Ventricular Systolic Dysfunction
James E. Udelson et al.
CIRCULATION-HEART FAILURE (2010)
EURObservational Research Programme: The Heart Failure Pilot Survey (ESC-HF Pilot)
Aldo P. Maggioni et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial
Shannon M. Dunlay et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Extracellular Cardiac Matrix Biomarkers in Patients With Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction and Heart Failure Insights From the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) Study
Wafae Iraqi et al.
CIRCULATION (2009)
Serum Cortisol as a Useful Predictor of Cardiac Events in Patients With Chronic Heart Failure The Impact of Oxidative Stress
Masayuki Yamaji et al.
CIRCULATION-HEART FAILURE (2009)
Use of Aldosterone Antagonists in Heart Failure
Nancy M. Albert et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients
Domingo A. Pascual-Figal et al.
EUROPEAN HEART JOURNAL (2008)
Acute heart failure in the emergency department: Short and long-term outcomes of elderly patients with heart failure
Justin A. Ezekowitz et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
NT-ProBNP reduction percentage during hospital stay predicts long-term mortality and readmission in heart failure
Valerio Verdiani et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2008)
Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)
Serge Masson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure
Antoni Bayes-Genis et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony
Friedrich M. Fruhwald et al.
EUROPEAN HEART JOURNAL (2007)
Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker
Colin Berry et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure
RP Frantz et al.
AMERICAN HEART JOURNAL (2005)
Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure - A substudy of the carvedilol prospective randomized cumulative survival (COPERNICUS) trial
F Hartmann et al.
CIRCULATION (2004)
Rates of hyperkalemia after publication of the randomized aldactone evaluation study
DN Juurlink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients
P Bettencourt et al.
CIRCULATION (2004)
Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors
AP Maggioni et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure
T Tsutamoto et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
分享论文
